HANGZHOU, China (BUSINESS WIRE) Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, today announced the successful completion of a pre-Series B financing exceeding $16 mil.
HANGZHOU, China (BUSINESS WIRE) Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, announced today that the National Medical Products Administration (NMPA) approved its c.
HONG KONG, Nov 10, 2022 - (ACN Newswire) - Global healthcare collaboration and innovation are key themes of the Hong Kong Trade Development Council (HKTDC)'s inaugural International Healthcare Week, currently
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.